Fundamental dimension Equity attribute | IGEXLeader $0.0004▼-20.00% Cap $2.85MP/E -16.1x QuantScore41/100 | CRYMPeer $0.00020.00% Cap $47.43KP/E -0.0x QuantScore35/100 | CVGRFPeer $0.02430.00% Cap $1.21MP/E -1.7x QuantScore24/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
33/100 |
84/100 |
38/100 |
Valuation Multiples, PEG & DCF upside | 50/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 29/100 | 23/100 | 25/100 |
Growth Revenue / earnings growth & margins | 50/100 | 33/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -16.1x | -0.0x | -1.7x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -16.5x | -0.4x | -1.2x |
Price / Sales | — | 3.5x | — |
Price / Free Cash Flow | 2.3x | -0.0x | -2.5x |
PEG ratio | 0.16 | -0.00 | 0.04 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 2 / 9 |
Altman Z-Score | 1.70 (Distress) | -102.23 (Distress) | -152.73 (Distress) |
Total debt / equity | 0.00 | -0.77 | -0.12 |
Quick ratio | 0.6x | 0.1x | 0.5x |
Interest coverage | — | -27.7x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | +74.4% | -24.3% | -174.1% |
Gross margin (TTM) | 0.0% | 100.0% | 0.0% |
Operating margin (FY) | — | -79560.2% | — |
FCF margin (FY) | — | -28624.7% | — |
5. Trailing price performancePrice change over period |
1M return | -33.3% | +0.0% | -11.4% |
3M return | -20.0% | +0.0% | -21.0% |
6M return | -42.9% | +0.0% | -17.9% |
Year to date | +33.3% | +0.0% | -67.6% |
1Y return | -20.0% | +19900.0% | -34.4% |
3Y return | -60.0% | -99.8% | -49.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.0001 -135.1% premium | $-0.0311 -15632.3% premium | $-0.0083 -134.3% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |